SUSTAINED RELEASE METHYLPHENIDATE FOR THE TREATMENT OF ADHD IN AMPHETAMINE ABUSERS: A PILOT STUDY
Kaydedildi:
KONSTENIUS, M., ET AL., SUSTAINED RELEASE METHYLPHENIDATE FOR THE TREATMENT OF ADHD IN AMPHETAMINE ABUSERS: A PILOT STUDY. DRUG AND ALCOHOL DEPENDENCE, Vol. 108, no. 1-2 (2010), p. 130-133.
Ref.
176579
Yer:
SIIS R.854 Archivo
Palabras clave:
Anfetaminas, Diagnóstico dual, Drogodependencias, Hiperactividad, Proyectos piloto, Trastornos de atención, Tratamiento, Suecia
Anfetaminas, Diagnóstico dual, Drogodependencias, Hiperactividad, Proyectos piloto, Trastornos de atención, Tratamiento, Suecia
Benzer Materyaller: SUSTAINED RELEASE METHYLPHENIDATE FOR THE TREATMENT OF ADHD IN AMPHETAMINE ABUSERS: A PILOT STUDY
- SUSTAINED RELEASE METHYLPHENIDATE: PHARMACOKINETIC STUDIES IN ADDH MALES
- Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder
- Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
- ADULT ADHD AND SUBSTANCE ABUSE: DIAGNOSTIC AND TREATMENT ISSUES
- AMPHETAMINE PRESCRIBING AS A HARM REDUCTION MEASURE: A PRELIMINARY STUDY
- NEUROCOGNITIVE STABILITY IN ASPERGER SYNDROME, ADHD, AND READING AND WRITING DISORDER: A PILOT STUDY